- Abstract Number: 042
Safety Analysis of Infliximab-dyyb as Compared to Infliximab in Pediatric Rheumatic Conditions
- Abstract Number: 138
Serious Infection Risk in Pediatric Patients with Low Immunoglobulin Levels Following Rituximab Treatment for Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA)
- Abstract Number: 140
Serum Biomarkers in a German Cohort of Patients with Systemic Juvenile Idiopathic Arthritis and Their Relationship to Response to Interleukin-1 Blockade
- Abstract Number: 005
Single Cell Sequencing of the Skin to Define Cell Populations of Interest in Localized Scleroderma (LS)
- Abstract Number: 192
Single Center Consensus of Prophylactic Treatment in Immunocompromised Children with Rheumatic Disease
- Abstract Number: 087
Standardizing Care and Fostering Systemic Autoinflammatory Disease (SAID) Research Through the CARRA Autoinflammatory Disease Network
- Abstract Number: 014
Successful Validation of a Rapid Point-of-care Test for Serum Calprotectin (MRP8/14) as Biomarker in Juvenile Idiopathic Arthritis
- Abstract Number: 088
Sun Protection Use in Patients Followed in a Pediatric Rheumatology Clinic in an Urban Setting
- Abstract Number: 122
Systemic Inflammation and Cognitive Dysfunction in jSLE Patients
2020 Pediatric Rheumatology Symposium
April 29-May 2, 2020
The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.